Sanofi - ADR (SNY) Social Stream



Sanofi - ADR (SNY): $38.98

-0.84 (-2.11%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

SANOFI (SNY) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering SNY.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-01 5 $69.5 $58 $66.125 $39.19 68.73%
2022-01-03 5 $69 $58 $65.625 $39.19 67.45%
2022-01-18 4 $67.5 $58 $63.833 $39.19 62.88%
2022-03-15 4 $68.5 $58 $64.166 $39.19 63.73%
2022-04-04 4 $66 $58 $63.333 $39.19 61.61%
2022-04-08 4 $66 $60 $64 $39.19 63.31%
2022-05-05 4 $72.5 $62 $66.833 $39.19 70.54%
2022-05-06 4 $72.5 $62 $67.833 $39.19 73.09%
2022-05-22 5 $72.5 $62 $66.875 $39.19 70.64%
2022-08-01 5 $69 $62 $65.5 $39.19 67.13%
2022-08-02 5 $69 $62 $64.925 $39.19 65.67%
2022-08-13 7 $69 $62 $64.925 $39.19 65.67%
2022-08-17 7 $69 $52 $62.425 $39.19 59.29%
2022-08-24 7 $69 $52 $60.75 $39.19 55.01%
2022-09-17 7 $62 $52 $57.125 $39.19 45.76%

The Trend in the Analyst Price Target


Over the past 46 weeks, SNY's average price target has gone down $9.

Over the past 46 weeks, SNY's average upside potential has been 30.38%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-03-17 4 66 58 63.333 52.60 20.4%
2022-04-04 4 66 58 63.333 52.55 20.52%
2022-04-08 4 66 60 64.000 56.75 12.78%
2022-08-01 5 69 62 65.500 48.90 33.95%
2022-09-10 7 62 52 57.125 40.80 40.01%

SNY Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.86 4 0 3 0 0 7

The Trend in the Broker Recommendations


Over the past 35 weeks, SNY's average broker recommendation rating worsened by 0.36.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • SNY has a lower variance in analysts' estimates than -172.07% of all US stocks.
  • To contextualize these metrics, consider that out of stocks in the large market cap category, SANOFI's number of analysts covering the stock is higher than 132.35% of them.
  • SANOFI's average analyst price target is higher than 1401.74% of Pharmaceutical Products stocks.
  • In the context of Pharmaceutical Products stocks, SANOFI's upside potential (average analyst target price relative to current price) is higher than 457.13% of them.

Stocks similar to SANOFI in the Pharmaceutical Products industry regarding analyst recommendations and price targets are RPRX, REGN, and RDY.

Make investment decisions regarding SNY using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4603 seconds.